title: New biomarkers and risk stratification in atrial fibrillation: simplicity and practicality matter.
authors.affiliation: From Life and Health Sciences, Aston Research Centre for Healthy Ageing, Aston University, Birmingham, United Kingdom (H.R.G.); University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.); and the Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark (G.Y.H.L.). h.r.griffiths@aston.ac.uk.
authors.forename: Helen R
authors.initials: HR
authors.lastname: Griffiths
authors.affiliation: From Life and Health Sciences, Aston Research Centre for Healthy Ageing, Aston University, Birmingham, United Kingdom (H.R.G.); University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.); and the Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark (G.Y.H.L.).
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D001281:Atrial Fibrillation / Q000097:blood*; D005260:Female; D055436:Growth Differentiation Factor 15 / Q000097:blood*; D006801:Humans; D008297:Male; D018384:Oxidative Stress / Q000502:physiology*; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D020521:Stroke / Q000097:blood*; D013923:Thromboembolism / Q000097:blood*
chemical_list: C526140:GDF15 protein, human; D055436:Growth Differentiation Factor 15; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban
keywords: Editorials; antithrombotic agents; biomarkers; bleeding; reactive oxygen species; stroke; thioredoxin